12:00 AM
Oct 26, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Pandemrix: Data

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K.
Product: Pandemrix ( GSK2340272A)
Business: Infectious
Molecular target: NA
Description: Split-virion, adjuvanted swine influenza A (H1N1) vaccine
Indication: Vaccinate...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >